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Smith-Magenis Syndrome Results in Disruption of CLOCK
Gene Transcription and Reveals an Integral Role for
RAI1 in the Maintenance of Circadian Rhythmicity
Stephen R. Williams,1,2 Deborah Zies,3 Sureni V. Mullegama,1 Michael S. Grotewiel,1
and Sarah H. Elsea1,4,*
Haploinsufficiency of RAI1 results in Smith-Magenis syndrome (SMS), a disorder characterized by intellectual disability, multiple
congenital anomalies, obesity, neurobehavioral abnormalities, and a disrupted circadian sleep-wake pattern. An inverted melatonin
rhythm (i.e., melatonin peaks during the day instead of at night) and associated sleep-phase disturbances in individuals with SMS, as
well as a short-period circadian rhythm in mice with a chromosomal deletion of Rai1, support SMS as a circadian-rhythm-dysfunction
disorder. However, themolecular cause of the circadian defect in SMS has not been described. The circadian oscillator temporally orches-
trates metabolism, physiology, and behavior largely through transcriptional modulation. Data support RAI1 as a transcriptional
regulator, but the genes it might regulate are largely unknown. Investigation into the role that RAI1 plays in the regulation of gene tran-
scription and circadianmaintenance revealed that RAI1 regulates the transcription of circadian locomotor output cycles kaput (CLOCK),
a key component of themammalian circadian oscillator that transcriptionally regulates many critical circadian genes. Data further show
that haploinsufficiency of RAI1 and Rai1 in SMS fibroblasts and the mouse hypothalamus, respectively, results in the transcriptional
dysregulation of the circadian clock and causes altered expression and regulation of multiple circadian genes, including PER2, PER3,
CRY1, BMAL1, and others. These data suggest that heterozygous mutation of RAI1 and Rai1 leads to a disrupted circadian rhythm
and thus results in an abnormal sleep-wake cycle, which can contribute to an abnormal feeding pattern and dependent cognitive
performance. Finally, we conclude that RAI1 is a positive transcriptional regulator of CLOCK, pinpointing a novel and important role
for this gene in the circadian oscillator.Introduction
Smith-Magenis syndrome (SMS,MIM182290) is a complex
genomic disorder that results from an interstitial deletion
of chromosomal region 17p11.2, including RAI1 (retinoic
acid induced one [MIM 607642]), or heterozygous
mutation of RAI1. Along with behavioral, skeletal, and
neurological abnormalities, sleep disturbance is a hallmark
of SMS.
Circadian rhythms are endogenous ~24 hr cycles
affecting and modulating physiological processes and
behavior found in organisms that range from bacteria to
mammals. The circadian oscillator enables organisms to
anticipate predictable changes in the environment and
temporally orchestrate their metabolism, physiology, and
behavior largely through transcriptional modulation.
Reports indicate that 75%–100% of all individuals with
SMS present with sleep disturbance, and this is one of
the early indicators that an individual might have
SMS.1,2 Although infants typically present with hypersom-
nolence early in life, sleep disturbance, including difficulty
falling asleep, inability to enter or maintain REM (rapid-
eye movement) sleep, reduced night sleep, shortened and
broken sleep cycles with frequent night-time and early-
morning awakenings and excessive daytime sleepiness,
begin in early toddlerhood and last well into adult-1Department of Human andMolecular Genetics, Virginia Commonwealth Uni
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The Amhood.3,4 Studies in older adults are limited; however, sleep
disturbance continues to be a common complaint among
families.
Several studies have implicated an inverted rhythm of
melatonin secretion as the root cause of the sleep distur-
bance, providing evidence that these circadian-rhythm
difficulties can complicate behavior and learning.5–8
Furthermore, individuals with RAI1 mutation also have
altered melatonin secretion, implicating RAI1 directly in
circadian function.9 However, complicating this analysis
is a report of a 17p11.2-deletion individual who has
normal melatonin secretion but who still has sleep distur-
bance, indicating a possible molecular role for RAI1 in the
sleep cycle and in the core molecular pathway of circadian
rhythm.4 Additionally, mice in which Rai1 has been
deleted have abnormal circadian behavior, including
a shortened period length, which was observed after
Rai1-deletion mice and wild-type (WT) littermates were
entrained to the 12 hr light/12 hr dark cycle and then
tested in constant darkness.10
Given the phenotypic consequences of RAI1 mutation
or deletion, RAI1must be involved in pathways associated
with developmental, behavioral, and neurological func-
tion and circadian rhythm,11 and identification of the
specific molecular changes and subsequent affected
pathways that result from RAI1 haploinsufficiency holdsversity School of Medicine, 1101 E. Marshall St., Richmond, VA 23298, USA;
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the potential for pharmaceutical-, behavioral-, or nutri-
tional-based interventions. Thus, we set out to investigate
the biological role of RAI1 and Rai1 in circadian rhythm.
Data show that RAI1 is a critical player in the maintenance
of the molecular clock, wherein haploinsufficiency of RAI1
results in the dysregulation of critical genes involved in
circadian biology.Material and Methods
Cell Culture
Unless otherwise noted, all cell lines used in this study were
cultured in high glucose Dulbecco’s Modified Eagle’s Medium
(DMEM [Invitrogen]) with 10% (v/v) FBS, 2 mM L-glutamine, and
1X antibiotic-antimycotic (Invitrogen) and were maintained at
37C in a 5% CO2 incubator. Fibroblasts utilized in this study
included GM0063712 (Coriell Cell Repository), BAB23913 (com-
mon SMS 17p11.2 deletion), SMS18214 (atypical SMS 17p11.2
deletion), and SMS17515 (RAI1mutation [p.1562Gln>Arg]). Fibro-
blasts were collected from skin biopsies obtained from consenting
participants in the National Human Genome Research Institute
of the National Institutes of Health under protocol number
01-HG-0109.
siRNA Knockdown of RAI1 in HEK 293T Cells
RAI1 in human embryonic kidney (HEK) 293T cells was knocked
down as previously described.16 Cells were reverse transfected
with Trans-it LT1 (Mirus Bio) to a final concentration of 45 nM
siRNA specific to RAI1 (Ambion) or with a 45 nM scrambled-
sequence control. After 24 hr, RNA was isolated with the RNeasy
kit according to the standardmanufacturer (Invitrogen) protocols.
Next, RNA was reverse transcribed with qScript (Quanta Biosci-
ences). Transcription levels were measured with Syber Green
Mastermix (Applied Biosystems [ABI]), and GAPDH was used as
the internal control for performing the standard DDCT relative
quantification. Sybr Green primers are as follows: forward 50-
CCGACAAGGGTCGCAAACA-30 and reverse 50-CTTTGTGGCAG
CACCCAATG-30 for RAI1; forward 50-ATGGGGAAGGTGAAG
GTCG-30 and reverse 50-GGGGTCATTGATGGCAACAATA-30 for
GAPDH; forward 50-TAAGGGGCAACAGTGGATTTG-30 and
reverse 50-CAGCCCTAACTTCTGCATAACTT-30 for CLOCK (circa-
dian locomotor output cycles kaput [MIM 601851]); forward
50-TTTGTGGCGATAAGTCCTCTGG-30 and reverse 50-CTTGGG
CAGGAATAAGAAGCAT-30 for RORA (MIM 600825); forward 50-
ATGTTGGAGGCATTAGATGGC-30 and reverse 50-TCCATGACAT
CCGACGGTAAA-30 for NPAS2 (MIM 603347); and forward 50-
GCATGGATGCTTACCCAACT-30 and reverse 50-AATCTTCCAATG
GCCACAAG-30 for BMAL2 (Entrez Gene 56938).
Mouse-Tissue Collection
Rai1þ/ mice were obtained from the Jackson Laboratories
(B6.129s7-Rai1tm1jrt/J; stock 005981)17 and were bred with WT
C57BI/6J females for the generation of Rai1þ/ and WT pups.
Genotyping was performed by PCR with primers specific to the
Rai1-targeted allele and the WT allele, as reported.17 Mice were
maintained in a 12 hr light/12 hr dark cycle and were fed normal
chow ad libitum. Equal numbers of healthy WT and Rai1þ/ male
and female mice were euthanized at 9–15 months of age either
during the day at ~8 hr Zeitgeber time (Zeitgeber time 0 ¼ 6 am)
or at night at ~16 hr Zeitgeber time. WT C57BI/6J and Rai1þ/942 The American Journal of Human Genetics 90, 941–949, June 8, 2micewere euthanizedbyCO2 anesthesia, and tissueswere collected
in accordance with standard protocols and frozen at 80C.
Quantitative PCR
Total RNA was isolated from mouse tissues, HEK 293T cells, and
SMS fibroblast cell lines with Trizol according to the manufac-
turer’s (Invitrogen’s) instructions. All cell lines were cultured for
the same period of time to the same cell density, and all samples
were processed independently according to standard protocols.
Fibroblasts were serum shocked 24 hr prior to RNA isolation
for the synchronization of cells. Prior to reverse transcription,
RNA quality and concentration were determined by standard
NanoDrop. First-strand cDNA synthesis was carried out with either
Invitrogen’s Superscript kit (with 4 mg of total RNA) or Quanta
Biosciences’s Qscript (with 2 mg of RNA) according to themanufac-
turers’ instructions. For quantitative real-time PCR, predesigned
Taqman MGB probes and primers from the Assays-on-Demand
Gene Expression Products (ABI) were used for all genes, both
human and mouse. All samples were run in triplicate in 10 ml
reaction volumes. PCR conditions were the default settings of
the ABI Prism 7900 HT Sequence Detection System. The cycle
threshold (Ct) was determined during the geometric phase of
the PCR amplification plots as recommended by themanufacturer.
Relative differences in transcript levels were quantified with the
DDCt method with GAPDH (MIM 138400) mRNA as an endoge-
nous control. All expression values are calculated relative to
control levels set at 1.0. Data were analyzed by 1 sample t tests
with an experimentally defined control value of 1.0 and a p value
< 0.05 as described before.18 Acquired data were analyzed with
Excel, and graphs were plotted with GraphPad Prism 4.
RAI1 Knockdown in U2OS-B Cells and Evaluation
of Live-Cell Circadian Phenotype by Bioluminescence
Rhythms
U2OS-B cells19 (~1.5 3 104 cells), which have a stably integrated
Bmal1-luciferase gene, were reverse transfected with Trans-it LT1
(Mirus Bio) to a final concentration of 15 nM, 30 nM, or 45 nM
siRNA specific to RAI1 (Ambion) or with a 15 nM scrambled-
sequence control in a 96-well tissue-culture plate suitable for
luciferase analysis. All conditions were plated six times for the
assessment of experimental variability. Cells were cultured in
DMEM (Invitrogen) with 10% (v/v) FBS, 2 mM glutamine, 1X
Anti-Anti (Invitrogen), and 0.1 mMD-Luciferin at 37C in a Tecan
luminometer as previously described.19 Luciferase readings were
taken every 15 min for 7 days. The first and last days of readings
were eliminated from the analysis because they were not reliable.
The data obtained for each well were detrended with a 24 hr
moving window average and smoothed with a 2 hr moving
average.19 Period length was determined by COSOPT analysis
with raw data as previously described.19,20
Chromatin Immunoprecipitation with Microarray
Chromatin immunoprecipitation with microarray (ChIP-Chip)
was described previously.21 In brief, HEK 293T cells were trans-
fected with the RAI1Flag plasmid, ChIP-Chip was processed with
mouse IgG Dynabeads (Invitrogen), and the monoclonal Flag
IgG antibody (Sigma Aldrich) was produced in mice with Nimble-
gen ‘‘ChIP sample preparation protocol v.2’’ (Roche Nimblegen)
according to the manufacturers’ protocols. Transfected cells
were treated with formaldehyde for the crosslinking of protein
complexes with nuclear chromatin. Protein-chromatin products012
were isolated, and crosslinks were reversed with heat treatment.
After reverse crosslink, chromatin products were whole-genome
amplified with the WGA2-10RXN kit (Sigma-Aldrich) as per
recommendation by Nimblegen. Arrays were processed by Nim-
blegen with the Nimblegen HG18 RefSeq promoter array, which
assays 50UTRs across the genome, according to standard manufac-
turer protocols. Data were preprocessed by Nimblegen according
to standard protocols. RAI1Flag binding sites were generated with
genomic data points, Peak_Start and Peak_End, from Nimblegen
preprocessed data files.Creation of Plasmids
For RAI1Flag, a RAI1 coding sequence was cloned into pEntr/D-
TOPO and transformed into One Shot Competent E. coli according
to the manufacturer’s (Invitrogen’s) instructions. Plasmid DNA
was isolated with the Fermentus GeneJET plasmidmini kit accord-
ing to standard manufacturer instructions. Inserts were confirmed
with RAI1 cDNA primers and were sequenced according to stan-
dard Sanger techniques. Next, RAI1pEntr/D-TOPO was recombined
with pDest26Flag22 for the creation of pDest26RAI1Flag according
to the standard gateway protocol provided by Invitrogen.
ForCLOCKLuc, thefirstCLOCK intronelementwasPCRamplified
according to standard techniques (forward primer 50-GGACCTTT
GCAAGAGCCCAAG-30 and reverse primer 50-GCAGAGCACAGA
GGGCTTTTAGGCCGATGT-30) and was cloned into a StrataClone
PCR Cloning vector according to the standard protocol provide by
the manufacturer (Agilent Technologies) for the creation of the
CLOCKStrata plasmid. The CLOCKStrata plasmid and the pGL3pro
vector (Promega Corporation) were digested with KpnI and SacI
(New England Biolabs) and were gel extracted with the QIAquick
Gel Extraction Kit according to standard manufacturer (QIAGEN)
protocols. The insert from CLOCKStrata was directionally ligated
into the pGL3pro vector for the creation of CLOCKLuc according
to standard T4 ligation protocols provided by the manufacturer
(Promega Corporation). The constructs shown in Figure 5 were
created as described above and in the supplemental data (see
Supplemental Methods and Table S1, available online). All inserts
were confirmed by standard Sanger sequencing.Transfections
HEK 293Tcells were maintained in 6-well plates according to stan-
dard culturing practices described above. Transfections with
pUC19, psvb-Gal, CLOCKLuc constructs (see Figure 5), and
RAI1Flag were performed with Lipofectamine 2000 according to
the manufacturer’s (Invitrogen’s) instructions. In brief, ~5 3 105
cells were plated in 2.0 ml of growth medium without antibiotics
24 hr prior to transfection. A total of 4 mg of total plasmid DNA,
with the use of pUC19 plasmid as ‘‘filler’’ DNA so that transfection
efficiencies were similar across all test groups, was diluted in 250 ml
OptiMEM Reduced SerumMedium (Invitrogen). Similarly, 10 ml of
Lipofectamine 2000 was diluted in 250 ml of OptiMEM Reduced
Serum Medium, mixed well, and incubated for 5 min. After incu-
bation, diluted plasmid DNA was mixed with diluted Lipofect-
amine 2000 to a total volume of 500 ml and was incubated for
20 min. Plasmid-Lipofectamine complexes (500 ml) were added
to each well and were mixed by rocking. The cells were then incu-
bated at 37C in a 5% CO2 incubator for 24 hr.Luciferase Assays
After the plasmid-DNA transfection and 24 hr incubation, cells
were washed with 2 ml Dulbecco’s phosphate-buffered salineThe Am(DPBS [Invitrogen]) and Tropix Glacto-Light (ABI); standard
protocol was used. In brief, 500 ml of lysis solution was added to
each well of the 6-well plate and scraped until all cells were
detached. Lysates were collected and centrifuged at 12,000 RPM
for 2 min so that the cell debris would pellet. Next, 50 ml of the
supernatant was transferred to four wells of a 96-well white lumin-
ometer plate. Two wells were treated with 70 ml diluted Galacton
substrate (1:100, reaction buffer diluent with Galacton) and incu-
bated for 30 min; then, 100 ml of Accelerator(-II) was added. One
hundred microliters of Steady-Glo Luciferase substrate (Promega
Corporation) was added to the two wells that did not contain
the diluted Galacton substrate. Each well was read with theWallac
1420 VICTOR2 luminometer (PerkinElmer) on a maximum linear
scale. We calculated the relative luciferase activity from each
individual transfection by dividing the average number of light
units from the wells containing the Steady-Glo Luciferase
substrate (Promega Corp) by the average number of light units
from the wells containing the Galacton substrate and Acceler-
ator(-II). The equation (average luc/average b-gal ¼ relative lucif-
erase activity) was used. Wells containing pUC19, psvb-Gal, and
CLOCKLuc constructs were used as baseline luciferase activity.
Each experiment was performed independently at least three
times in triplicate wells for every assay. We generated p values by
averaging relative luciferase activity from each independent study
and performing a two-tailed Student’s t test. Standard deviations
were generated with GraphPad Prism 4.
Statistical Analyses
Figures 2B and 2C were generated with GraphPad Prism 4 software
and then subjected to ANOVA followed by Dunnett’s test. All
other statistics were performed with a standard 1 sample Student’s
t test. For the analysis, individual values for each test group were
uploaded to the St. John’s University Department of Physics
statistics website. Statistical significance was determined at a cutoff
of p% 0.05. All plots were generated with GraphPad Prism 4.Results
Knockdown of RAI1 Results in Altered Expression
of the Key Circadian Components
Numerous studies have shown that when a major compo-
nent of the circadian system is eliminated or modulated,
significant downstream effects can occur.19,23 To examine
our hypothesis that RAI1 is a component of the circadian
feedback loop, we knocked down RAI1 in HEK 293T cells
to ~50% of normal expression (Figure 1). Consistent with
the prediction that RAI1 plays a role in the maintenance
of correct transcription of circadian components, the
data show significant dysregulation of all tested circadian
transcripts (Figure 1). When RAI1 expression is reduced
by ~50% in HEK 293T cells, expression of CLOCK, the
‘‘master regulator’’ of the central circadian clock, is reduced
to ~50%. Furthermore, in addition to reduced CLOCK
expression, genes that CLOCK directly regulates and
other essential components of the circadian feedback
loop, including RORC (MIM 602943), RORA (MIM
600825), PER3 (MIM 603427), CRY1 (MIM 601933),
CRY2 (MIM 603732), NR1D2 (MIM 602304), and NR1D1
(MIM 602408), also have significantly reduced or alterederican Journal of Human Genetics 90, 941–949, June 8, 2012 943
Figure 1. siRNA Knockdown of RAI1 in HEK 293T Cells Alters
Circadian-Gene Expression
Circadian-gene expression in HEK 293T cells treated for knock-
down of RAI1 by siRNA. Data shown are an average of three
independent experiments performed in triplicate. Relative gene
expression is shown (control siRNA is shown in black, and RAI1
siRNA is shown in white). Bars represent standard deviation. The
quantification of the test gene is compared to that of the house-
keeping gene GAPDH. All siRNA-treated samples are statistically
different than controls, as shown by asterisks, which indicate
p values < 0.05 (calculated with Student’s t test). Error bars repre-
sent the standard deviation from the mean.expression (Figure 1). These genes represent the major
families of genes targeted by CLOCK and are all essential
components of the feedback loop of transcription. These
data show that haploinsufficiency of RAI1 results in sig-
nificant disruption of circadian expression of core com-
ponents in vitro, indicating a major role for RAI1 in
maintaining transcription of these genes. Additionally,
these data lend credence to the theory that RAI1 has
a primary role in circadian-component regulation and are
key to understanding the foundation of the SMS circadian
phenotype.Knockdown of RAI1 in U2OS-B Cells Results
in a Shortened Period Length and Dampened
Amplitude of Bmal1 Expression
To further investigate the role of RAI1 in circadian rhyth-
micity, we ultimately knocked down RAI1 to ~50% of
endogenous levels in a dose-dependent fashion; these
levels are consistent with theoretical expression in SMS
subjects. To accurately assess the circadian cycle over
a long period of time, we utilized a transgenic cell line
that carries the firefly luciferase gene under the control of
the Bmal1 promoter (Bmal1Luc).19 BMAL1 cycles with great
accuracy and with robust expression, so its expression is
a reliable measure of overall circadian stability. As seen in
Figure 2, dose-dependent knockdown of RAI1 results in
a significantly shortened period length of approximately
1 hr (Figures 2A and 2B) and decreased amplitude of
Bmal1Luc expression in U20S-B cell lines (Figures 2B and
2C). Dampened Bmal1Luc expression was not surprising
because it correlates with the reduced BMAL1 seen in944 The American Journal of Human Genetics 90, 941–949, June 8, 2Figure 1. However, it is worth noting that depending on
the level of CLOCK knockdown in vitro, BMAL1 amplitude
can be dampened significantly (this correlates with the
data that we present), but the fact that it can also increase
points to the level of fine tuning that occurs in the circa-
dian feedback loop.24 These data show that reduction in
RAI1 expression can affect the circadian system over time
in vitro, further indicating that RAI1 is a key component
in the maintenance of proper circadian rhythms. Impor-
tantly, these data are consistent with a report indicating
that haploinsufficiency of Rai1 in mice results in a short-
ened-period phenotype as well.10
Dysregulation of Circadian Genes in SMS Fibroblasts
Human fibroblasts follow a rhythmicity of ~24 hr in vitro
just as they would in vivo. To assess the circadian cycling
of a panel of core circadian genes, including RAI1, CLOCK,
and NR1D1, we took RNA samples from unaffected
(GM00637),18 common SMS 17p11.2 deletion
(BAB239),19 atypical SMS 17p11.2 deletion (SMS182),20
and RAI1mutation (SMS175 [p.1562Gln>Arg]21) cell lines.
All cells were synchronized by serum shock 24 hr before
measures were taken so that we could assess any desynch-
ronization from a common starting point of transcription.
Our data show that transcript levels of all assessed genes
(RAI1, CLOCK, PER1, ARNTL2, NR1D1, and CRY1) are dys-
regulated when compared to those of normal fibroblasts
(Figure 3). These data further support a role for RAI1 in
the regulation of circadian genes and illustrate that when
RAI1 is haploinsufficient as a result of deletion or muta-
tion, transcriptional regulation of the molecular clock is
disrupted. Although some aspects of the circadian feed-
back loop of expression have been analyzed in SMS
subjects,25 these data show a true profile of the core circa-
dian components in SMS tissue and that these circadian
alterations are associated with both deletion and mutation
of RAI1.
Dysregulation of Circadian Genes in the Rai1þ/
Mouse Hypothalamus
Rai1þ/ mice, which harbor a targeted mutation of Rai1,
are obese and hyperphagic, have decreased sensitivity
to pain, and exhibit reduced muscle strength.17,21,26,27 In
addition, a chromosomal deletion model of SMS, the
Df(11)17 mouse, has the same overall phenotype as the
Rai1þ/ mouse but also has an altered circadian rhythm,
which has not been assessed in the Rai1þ/ mouse
model.17 Expression analysis of Rai1 and Clock in the
Rai1þ/ mouse hypothalamus during the light phase
(~8 hr Zeitgeber) showed reduced expression of both genes
(Figure 4A). The suprachiasmatic nucleus (SCN) lies within
the hypothalamus and is the region of the brain that is
responsible for controlling the central circadian rhythm.
Furthermore, we analyzed the expression of downstream
targets of Clock and other essential components of the
circadian feedback loop, including Per2, Npas2, and
Nr1d2, during the light phase, and all genes assessed had012
Figure 2. RAI1 siRNA Knockdown in
U2OS-B Cells Results in a Shortened
Period and Reduced Amplitude of Bmal1
Expression
Luciferase expression from U2OS-B cells
treated with siRNA specific to RAI1 over
a 5 day period and COSOPT analysis of
period length are shown. Data reflect
all luciferase measurements taken. The
average for each siRNA concentration is
compared to the control average, and aster-
isks represent p values < 0.001 (calculated
with ANOVA and Dunnett’s test). Data
shown are representative of three indepen-
dent experiments. Error bars represent the
standard deviation from the mean.
(A) The x axis represents time, and ticks are
shown in 4 hr increments. The y axis repre-
sents normalized and averaged luciferase
activity of six wells for each experimental
condition.
(B) Average period length of six wells after
COSOPT analysis.
(C) Average amplitude of circadian wave.reduced expression when compared to those of the WT
C57Bl/6J littermates (Figure 4A). These data illustrate
dysregulation of diurnal gene expression in the Rai1þ/
mouse hypothalamus.
We next evaluated diurnal gene expression in the mouse
hypothalamus during the night (~16 hr Zeitgeber) to
ensure that expression differences remained and were
not restored as a result of any external cues, such as the
absence of light (Figure 4B). The data show that during
the dark phase, the expression of core circadian genes isFigure
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RAI1 Transcriptionally Activates CLOCK
via an Intron 1 Enhancer Element
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Figure 4. Altered Expression of Circadian Genes in Rai1þ/
Mouse Hypothalamus during Light and Dark Phases
(A) Circadian-gene expression in mouse hypothalamus extracted
fromWT (black bars) or Rai1þ/ mice (white bars) during the light
phase at 8 hr Zeitgeber time.
(B) Circadian-gene expression in mouse hypothalamus extracted
from WT (black bars) or Rai1þ/ mice (white bars) during the
dark phase at 16 hr Zeitgeber time. All values shown are the
mean of at least three independent samples analyzed in triplicate.
The quantification of the test gene is compared to that of the
housekeeping gene Gapdh. Error bars represent the standard devi-
ation from themean. Asterisks indicate p< 0.05 by Student’s t test.largely unknown.29 Using peak data acquired from our
chromatin immunoprecipitation for RAI1Flag and microar-
ray analysis (ChIP-chip), we identified a ~389 bp region in
which RAI1Flag was bound. This element resides in CLOCK
intron 1 (hg18, NCBI build 36, Chr4: 56,072,089–
56,072,440). Initially, we cloned a 721 bp genomic region
containing this element (CLOCKLuc) and performed lucif-
erase assays to assess the ability of RAI1 to activate tran-
scription via this potential enhancer element (Figure 5;
see Material and Methods).
When the RAI1Flag construct was transfected with
CLOCKLuc with either a (þ) or a () strand, luciferase
activity increased more than three times (Figure 5). We
next designed deletion constructs to assess the smallest
possible region that RAI1 could activate. When
CLOCKDel1, CLOCKDel2, CLOCKDel3, and CLOCKDel4
were each activated by RAI1, luciferase activity was at
least two times greater than that of each construct alone.946 The American Journal of Human Genetics 90, 941–949, June 8, 2When RAI1 was transfected with the smallest construct,
CLOCKDel5, luciferase activity increased three times
more than that of CLOCKDel5 alone, narrowing the
enhancer binding region to 51 bp. This 51 bp region is
the smallest tested region with the ability to enhance
transcription via RAI1 (Figure 5). Additionally, when
CLOCKDel6, which contains the 50 end of the original
CLOCKLuc, was tested, RAI1 did not have the ability to
enhance transcription of this construct. These data indi-
cate that CLOCKDel6 is not necessary for transcription
control of this region, further validating that the 51 bp
CLOCKDel5 is the most important location for RAI1
enhancer activity. Control experiments showed that
RAI1 does not have the ability to enhance luciferase
activity of the pGL3 promoter plasmid without an insert.
All together, the ChIP-Chip and luciferase data suggest
that RAI1 binds, directly or in a complex, to the first
intron of CLOCK and enhances its transcriptional acti-
vity in vitro, supporting RAI1 as a positive regulator of
CLOCK and an important part of the circadian loop of
transcription.Discussion
Mammalian circadian rhythm is an essential regulator of
not only the sleep-wake cycle but also body temperature,
feeding cycles, hormone secretion, drug and xenobiotic
metabolism, glucose homeostasis, and cell-cycle progres-
sion.30 The master regulator of the circadian clock resides
in the SCN located in the mammalian hypothalamus.
The primary synchronizer of this clock is the 24 hr light/
dark cycle, throughout which a feedback loop of gene tran-
scription and the subsequent degradation of gene products
occur and which signals the mentioned processes to react
accordingly. Because of the complexity of this circadian
loop, disturbances in the timing of gene expression can
have a major impact on not only sleep pattern but also
disease susceptibility and behavioral stability. Genes
involved in fatty-acid metabolism, energy metabolism,
and cholesterol biosynthesis are expressed in a circadian
manner,30 and it has been shown that circadian disruption
results in increased risk of not only sleep disturbance but
also obesity,31 cancer,30 bipolar disorder, and schizo-
phrenia.32 Interestingly, the ClockD19/D19 mice that harbor
a homozygous mutation in Clock are obese and hyper-
phagic,33 a phenotype similar to that seen in RAI1þ/
mice.21 Furthermore, altered circadian rhythm has been
linked to bipolar disorder,34 and variants in CLOCK have
been linked to sleep disorders in humans.35
The mammalian CLOCK is thought to be the master
regulator of the central clock of circadian rhythm. The
protein product of CLOCK is a basic-helix-loop-helix tran-
scription factor and heterodimerizes with BMAL1 to acti-
vate transcription of a variety of downstream genes essen-
tial for the proper modulation of circadian rhythm. The
period genes (PER1, PER2, and PER3), the cryptochrome012
Figure 5. RAI1 Activation of CLOCK Gene Enhancer Element
HEK 293T cells were transfected in triplicate with three constructs (RAI1, b-GAL, and one of the test luciferase plasmids [CLOCKLuc,
CLOCK()Luc, CLOCKDel1, CLOCKDel2, CLOCKDel3, CLOCKDel4, CLOCKDel5, or CLOCKDel6]) for a total of eight different combinations.
The RAI1 plasmid represents the cDNA sequence of RAI1 in the pDEST26 vector (RAI1Flag). All assays were performed in triplicate. The x
axis compares the luciferase activity of the luciferase constructs activated by RAI1 with that of the constructs alone, which are repre-
sented by the hatched line. Data shown are the average of three independent biological replicates for each construct. Error bars represent
the standard deviation from themean. Details for the creation of each construct are provided in theMaterial andMethods section and in
the Supplemental Methods.genes (CRY1 and CRY2), the nuclear receptor subfamily 1
group D member 1 (NR1D1/Rev-Erba), and RAR-related
orphan receptor A genes (RORA, RORB, and RORC) are all
regulated by the CLOCK/BMAL1 complex. Additionally,
a recent report showed that JARID1a activates the
CLOCK/BMAL1 complex and promotes trafficking to the
PER2 promoter, where it inhibits histone methylation
and thus allows transcription of PER2.36 Data presented
here show that knockdown, deletion, or mutation of
RAI1 results in altered expression of genes from all of these
downstream gene families whether in mice, human SMS
cell lines, or in vitro siRNA knockdown experiments.
Furthermore, we were able to show that RAI1 is a direct
regulator of CLOCK, adding an important element to the
complex circadian feedback loop of transcription.
The circadian-rhythm defect seen in SMS is thought to
contribute to a more severe behavioral phenotype.37 Data
suggest that when sleep rhythmicity is improved, behavior
and learning improve.5,7,32,38 Additionally, a survey of SMS
caregivers indicated that partial alleviation of the sleep
disturbance in individuals with SMS results in behavioral
improvement.7,39 Thus, it is imperative to understand
the molecular defects that result from RAI1 mutation or
deletion because these defects signal global disruption of
the central circadian clock in SMS.
We also show that RAI1 is a regulator of CLOCK, which
might have broad implications in behavior and metabo-
lism, pinpointing RAI1 as a new candidate for sleep distur-
bance and mental-health disorders in the general popula-
tion. The current hypothesis with regard to the invertedThe Amcircadian rhythm documented in SMS is that an inverted
secretion of melatonin causes sleep disturbance.5,7,32,38
The data presented here suggest that this inverted circa-
dian rhythm is probably due to a dysregulation of circa-
dian-gene expression and that the inverted melatonin
secretion observed in the majority of cases is probably a
byproduct of this dysregulation. Further supporting our
hypothesis are the facts that C57BL6 mice (which are the
background strain for all mice in these experiments) do
not secrete melatonin40 yet have altered circadian rhythm
when Rai1 is haploinsufficient and that although not all
individuals with SMS have inverted melatonin, they do
have significant sleep disturbance similar to those who
have melatonin inversion.4,8 However, these data do not
exclude the possibility that RAI1 might be acting through
multiple channels to influence circadian rhythm and
not exclusively through CLOCK. Additional studies corre-
lating hormonal regulation and external cues, such as
feeding and light, in both humans and animals will be
required for fully understanding the clinical implications
of these findings and for identifying effective, targeted
treatment.
RAI1 was recently shown to bind nucleosomes and to
have low nuclear mobility, suggesting its ability to modify
chromatin and regulate gene expression,41,42 but until
now, true molecular evidence for RAI1 function has not
been tractable. All together, these data suggest that RAI1
plays an important role in maintaining circadian rhyth-
micity in vitro and in vivo, and because circadian rhythms
impact development, sleep, and behavior, these findingserican Journal of Human Genetics 90, 941–949, June 8, 2012 947
should help to further delineate the pathways involved in
syndromes wherein these functions are disrupted.Supplemental Data
Supplemental Data include one table and Supplemental Methods
and can be found with this article online at http://www.cell.com/
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